General Electric Co.

NYSE:GE  
104.41
+1.67 (+1.62%)
Products

GE Healthcare Receives FDA Approval For Change In Contraindications In Prescribing Information For Optisontm

Published: 10/05/2021 11:23 GMT
General Electric Co. (GE) - GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for Optisontm.
GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for Optisontm.